adenocarcinoma

(redirected from clear cell adenocarcinoma)
Also found in: Thesaurus, Medical, Encyclopedia.

ad·e·no·car·ci·no·ma

 (ăd′n-ō-kär′sə-nō′mə)
n.
A malignant tumor originating in glandular tissue.

ad′e·no·car′ci·nom′a·tous (-nŏm′ə-təs, -nō′mə-təs) adj.

adenocarcinoma

(ˌædɪnəʊˌkɑːsɪˈnəʊmə)
n, pl -mas or -mata (-mətə)
1. (Pathology) a malignant tumour originating in glandular tissue
2. (Pathology) a malignant tumour with a glandlike structure

ad•e•no•car•ci•no•ma

(ˌæd n oʊˌkɑr səˈnoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
1. a malignant tumor arising from secretory epithelium.
2. a malignant tumor of glandlike structure.
[1885–90]
ad`e•no•car`ci•nom′a•tous (-ˈnɒm ə təs, -ˈnoʊ mə-) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.adenocarcinoma - malignant tumor originating in glandular epitheliumadenocarcinoma - malignant tumor originating in glandular epithelium
carcinoma - any malignant tumor derived from epithelial tissue; one of the four major types of cancer
prostate cancer, prostatic adenocarcinoma - cancer of the prostate gland
Translations

ad·e·no·car·ci·no·ma

n. adenocarcinoma, cáncer maligno que se origina en una glándula.

adenocarcinoma

n adenocarcinoma m
References in periodicals archive ?
Adenocarcinoma occurring in the proximal female urethra can be in 2 broad classifications: clear cell adenocarcinoma or non-clear-cell adenocarcinoma.
Nonintestinal adenocarcinoma can be clear cell adenocarcinoma or adenocarcinoma of nonspecific type.
The women also had 40 times the risk of developing a rare cancer of the vagina among young women, called clear cell adenocarcinoma - although the number of cases remained about one in 1000.
Clear cell adenocarcinoma in a female urethral diverticulum.
The first report of an effect of an ED on human development was the seminal observation by Herbst (Herbst and Bern 1981) of eight cases of clear cell adenocarcinoma (CCA) of the vagina in young women who had been exposed in utero to DES.
Histology at that time revealed a clear cell adenocarcinoma.
The hormone was banned for use during pregnancy in 1975 after research in the United States established that girls born to women who had taken the hormone had a higher rate of a rare form of vaginal cancer, clear cell adenocarcinoma.